| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2425 | |||||||||||||||||||||||
| Submitter : | Mr. Kenneth Nowak | Date & Time: | 12/01/2006 08:12:17 | |||||||||||||||||||||
| Organization : | Mr. Kenneth Nowak | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| [2006D0383]Please limit your recommendation to cell lines originating from non-controbersial sources instead of cells derived from aborted babies. In order for us to use vaccines we must be sure they were not created from aborted babies. | ||||||||||||||||||||||||